Markets & Regulations

Biogenerics debate rumbles on

Biogenerics debate rumbles on

Representatives of the pharmaceutical and biotechnology industries
presented strong opposition to the concept of biogenerics at a
recent meeting convened by the US Food and Drug Administration. As
expected, their argument centred...

Follow us

Products

View more

Webinars